Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Panbela Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +5 vs. Q4 2022
- Shares held
- 1.94M
- +1.46M (+301.0%) vs. Q4 2022
- Total value
- $857.7K
- +$823.2K (+2,383.0%) vs. Q4 2022
- New holders
- 12
- 0 more added
- Sold out
- 7
- 8 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 11 | $115.8K |
| Q3 2023 | 7 | $71.8K |
| Q2 2023 | 9 | $945.1K |
| Q1 2023 | 20 | $857.7K |
| Q4 2022 | 15 | $34.5K |
| Q3 2022 | 17 | $801.0K |
| Q2 2022 | 13 | $111.0K |
| Q1 2022 | 16 | $1.78M |
| Q4 2021 | 17 | $1.72M |
| Q3 2021 | 18 | $2.41M |
| Q2 2021 | 17 | $3.12M |
| Q1 2021 | 15 | $2.74M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 12 | $0 | 0.00% | −488−97.6% | Reduced |
| Northwestern Mutual Wealth Management Co | 15 | $7 | 0.00% | −618−97.6% | Reduced |
| Wells Fargo & Company | 44 | $19 | 0.00% | −157−78.1% | Reduced |
| Bank of America Corp | 71 | $31 | 0.00% | −2,786−97.5% | Reduced |
| Advisor Group Holdings, Inc. | 77 | $34 | 0.00% | −3,038−97.5% | Reduced |
| Morgan Stanley | 812 | $359 | 0.00% | −31,688−97.5% | Reduced |
| Commonwealth Equity Services, LLC | 10,000 | $4.00K | 0.00% | +10,000 | New |
| Two Sigma Investments, LP | 10,043 | $4.44K | 0.00% | +10,043 | New |
| HighTower Advisors, LLC | 10,185 | $5.00K | 0.00% | +10,185 | New |
| Moneta Group Investment Advisors LLC | 11,999 | $5.31K | 0.00% | +11,999 | New |
| Warberg Asset Management LLC | 20,000 | $8.80K | 0.00% | +20,000 | New |
| UBS Group AG | 32,771 | $14.5K | 0.00% | −180,727−84.7% | Reduced |
| Two Sigma Securities, LLC | 48,050 | $21.2K | 0.00% | −18,115−27.4% | Reduced |
| State Street Corp | 53,142 | $23.5K | 0.00% | +53,142 | New |
| HRT Financial LP | 68,549 | $30.0K | 0.00% | +68,549 | New |
| Anson Funds Management LP | 163,024 | $72.1K | 0.02% | +163,024 | New |
| Altium Capital Management LP | 335,324 | $148.3K | 0.09% | +335,324 | New |
| Hudson Bay Capital Management LP | 355,000 | $157.0K | 0.00% | +355,000 | New |
| CVI Holdings, LLC | 394,901 | $174.6K | 0.07% | +394,901 | New |
| Sabby Management, LLC | 426,363 | $188.5K | 0.70% | +426,363 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −54,541−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −22,659−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −20,608−100.0% | Sold out |
| Oxford Financial Group Ltd | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −13,958−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,622−100.0% | Sold out |